(Q48371652)

English

The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition

scientific article published on 19 March 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

object named as

Fuat Balci

2

0 references

author name string

Neil E Paterson

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

Una Campbell

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

Berend E Olivier

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

Taleen Hanania

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

language of work or name

0 references

publication date

19 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

25

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

1357-1364

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

BIMT 17: a putative antidepressant with a fast onset of action?

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Effects of corticotropin releasing factor, desipramine and haloperidol on a DRL schedule of reinforcement.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Can the DRL 72s schedule selectively reveal antidepressant drug activity?

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Differential effects of imipramine in rats as a function of DRL schedule value.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Preclinical evidence on the psychotropic profile of fluvoxamine

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Similar effects of antidepressant and non-antidepressant drugs on behavior under an interresponse-time greater than 72-s schedule.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

DRL interresponse-time distributions: quantification by peak deviation analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Effects of SSRIs on sexual function: a critical review

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

"Broad spectrum" antidepressants: is more better for the treatment of depression?

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Treatment resistant depression: methodological overview and operational criteria

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Medication augmentation after the failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Flesinoxan shows antidepressant activity in a DRL 72-s screen

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Comparative efficacy of antidepressants

1 reference

https://api.crossref.org/works/10.1177%2F0269881110364272

21 January 2018

Identifiers

10.1177/0269881110364272

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/20305042

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48371652&oldid=2196040729"